Mike this will still be a product of ours that wil
Post# of 85119
https://www.reuters.com/finance/stocks/compan...le/UNVC.PK
Univec, Inc. (Univec), incorporated on October 7, 1996, is an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The physician and pharmaceutical services division assists pharmaceutical companies in marketing, fulfillment and tracking drug samples via an online system connecting pharmacies and managed payment providers. The Company also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government.
Univec commenced production and sales of its 1 cubic centimeter auto-disable syringes (AD-syringes), which are designed to make accidental or deliberate reuse difficult. The accidental or deliberate reuse of syringes is a frequent cause of the spread of the human immunodeficiency (HIV) and hepatitis viruses, as well as other blood-borne pathogens. Univec has received 510(k) clearance from the United Sates Food and Drug Administration (FDA) to market its AD-Syringes in the United States.
Univec also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government, and requirements of the occupational safety and health administration (OSHA). Univec has FDA approval for an extendible barrel sleeve syringe used in the sliding sheath syringes based on technology licensed by Univec.
Univec has developed a Bifurcated Needle Safety Syringe specifically designed to comply with the federal needlestick safety and prevention act of the United States government. Univec has been granted 510(k) clearance by the FDA. The device is intended for use in administering smallpox vaccines in response to potential bio-terrorist threats. The needlestick safety mandate requires all United States healthcare providers to evaluate and implement safer medical devices under their OSHA exposure control plans.
Needlestick prevention devices are designed to prevent accidental puncture injuries to health care workers and patients before, during, and after the use of hypodermic syringes and needles. Statistics indicate that less than 1% of all reported HIV infections in the United States are attributed to needlestick injuries.
Univec has developed a 1 cubic centimeter AD-Syringe for aspirating and non-aspirating applications, which are ideally suited for dispensing accurate dosages of allergy, immunization and insulin medicines. The Company’s 1 cubic centimeter AD-syringe can deliver dosages of up to .95 cubic centimeter.
The Company competes with Becton, Dickinson, Tyco, Terumo, Bader, Caremark and Medco Health.